BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.
about
Role of microRNAs in the resistance of prostate cancer to docetaxel and paclitaxelNon-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer MetabolismRegulation of mesenchymal phenotype by MicroRNAs in cancerA microRNA code for prostate cancer metastasis.MicroRNAs targeting prostate cancer stem cellsControl of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 GenesMicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients' samplesThe role of epithelial plasticity in prostate cancer dissemination and treatment resistancep63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model.ΔNp63α Transcriptionally Regulates the Expression of CTEN That Is Associated with Prostate Cell Adhesion.MicroRNA‑21 regulates the expression of BTG2 in HepG2 liver cancer cellsDifferential MIR-21 expression in plasma from mesenteric versus peripheral veins: an observational study of disease-free survival in surgically resected colon cancer patients.A predictive signature for therapy assignment and risk assessment in prostate cancer.Role of Btg2 in the progression of a PDGF-induced oligodendroglioma modelRecruitment of normal stem cells to an oncogenic phenotype by noncontiguous carcinogen-transformed epithelia depends on the transforming carcinogen.MicroRNAs and epithelial-mesenchymal transition in prostate cancer.Roles of microRNAs during prostatic tumorigenesis and tumor progression.Non-coding RNAs in Prostate Cancer: From Discovery to Clinical Applications.The emerging role of noncoding RNA in prostate cancer progression and its implication on diagnosis and treatment.The role of microRNAs in prostate cancer progression.Deciphering the function of non-coding RNAs in prostate cancer.Syndecan-1 up-regulates microRNA-331-3p and mediates epithelial-to-mesenchymal transition in prostate cancer.Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes.Androgen receptor and miR-206 regulation in prostate cancer.Down-regulated miR-15a mediates the epithelial-mesenchymal transition in renal tubular epithelial cells promoted by high glucose.Emerging role of microRNA-21 in cancer.Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells.Expression and significance of miRNA-21 and BTG2 in lung cancer.Association of microRNA-21 expression with clinicopathological characteristics and the risk of progression in advanced prostate cancer patients receiving androgen deprivation therapy.Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype.KH-type splicing regulatory protein is involved in esophageal squamous cell carcinoma progression.BTG2 Is Down-Regulated and Inhibits Cancer Stem Cell-Like Features of Side Population Cells in Hepatocellular Carcinoma.MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.Deciphering microRNA targets in pancreatic cancer using miRComb R package.A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer.Emerging biomarkers in the diagnosis of prostate cancer.Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer.
P2860
Q26769599-B955DF32-6EC5-4DF1-9E16-E508B824E508Q26774456-36A598CF-C4D6-4F9F-B3D1-6893C84723DAQ27009506-742F4B08-7C68-447C-9004-725ACF3815ADQ27310006-1356B35C-675F-468F-9766-BE0943F7E154Q28081039-DFC929E3-71F4-4690-8E3E-3A8D169A49F8Q28261895-EBEC0EC8-105C-4D3D-8CA7-DE7862129A50Q30859743-7B45F18E-BAD4-4CC3-8EB6-2A8A4FA15DDCQ34505037-73759F2B-E3DA-4471-845A-A9C403C41D20Q34712604-CEE6BCA8-521C-49C0-BCDF-5DC77181C773Q35897788-B127AAD2-16CE-4CC6-8511-55AFD2D86629Q36089730-23FEBEC9-DBFD-4F4E-A2C6-04A0728A280EQ36152800-C9DD873C-FA9A-4062-9E16-78AEAE538190Q36363301-AD8C66F4-7824-46BB-8DE4-25834C1213E9Q36432526-FF6C38C0-5DB0-41A0-AA66-44042E512701Q37072641-CE7D2910-5690-4ACD-BB14-4FA1230C1098Q37687205-3B093C0D-A0B2-454F-9738-1AC5C68E495CQ38086009-F9C53F40-2D37-41D4-BCA3-393878ACD47FQ38667234-2EF0A6F3-842B-4F52-B633-AB7F06D6421BQ38674130-2969F8E5-9FF3-48B5-A71B-20ABD6BB6876Q38712604-FA828739-FCB3-45E2-AB98-CBC00C73D519Q38843392-3B677AFB-623C-424A-B7EC-DFD2FEF2A429Q38844891-C01EBE8B-5EDD-44F3-BCE1-2C1CC2FB77D4Q38896410-CC5364CA-52E3-484E-8F63-235487C055EBQ38946793-42C252BD-E08B-4E40-87B2-EFBCC32A0EECQ38965204-DB3E20C2-C4ED-45C3-9D7D-995C8EA271F3Q38971467-C6A0352C-2577-4493-8429-A3366EF24E4BQ38998624-DBABFFA6-B497-4FF1-88DC-FA88FFDA0AB2Q39125495-BD3CC47D-8192-4635-8C53-2CBE23A50778Q39867322-CBF543DC-896F-42CB-94B1-A623FF421093Q42654111-70D0F6C0-DAB3-49FC-A6BF-435B27DBBEF6Q47133362-1265698A-BDF8-493E-A571-421F3B0B020FQ47446427-0BD9DC3A-09D5-44A8-B5EA-314C87A07F50Q49275839-65C073A8-4CBE-42D6-8428-E77FC81F8D26Q50101267-C52FC55D-71DB-4CBF-A167-7228C9E17552Q52587816-FE8D6D31-4C25-42F5-932F-FBFE5CC767FFQ54964875-AB063CD5-0C64-493C-A4E0-BF17C3569B14Q55181079-B714122F-9E29-4C11-A003-595F2EDE45F3
P2860
BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
BTG2 loss and miR-21 upregulat ...... helial-mesenchymal transition.
@en
BTG2 loss and miR-21 upregulat ...... helial-mesenchymal transition.
@nl
type
label
BTG2 loss and miR-21 upregulat ...... helial-mesenchymal transition.
@en
BTG2 loss and miR-21 upregulat ...... helial-mesenchymal transition.
@nl
prefLabel
BTG2 loss and miR-21 upregulat ...... helial-mesenchymal transition.
@en
BTG2 loss and miR-21 upregulat ...... helial-mesenchymal transition.
@nl
P2093
P2860
P50
P356
P1433
P1476
BTG2 loss and miR-21 upregulat ...... thelial-mesenchymal transition
@en
P2093
A Cannistraci
A Pagliuca
M Patrizii
R De Maria
P2860
P2888
P304
P356
10.1038/ONC.2012.194
P407
P50
P577
2012-05-21T00:00:00Z